Clinical trial
A Phase 3 Open-Label Extension Study to Evaluate the Long-Term Safety of Omiganan Topical Gel in Subjects With Rosacea
NCT02576847 is registered in ClinicalTrials.gov with Maruho Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3 Open-Label Extension Study to Evaluate the Long-Term Safety of Omiganan Topical Gel in Subjects With Rosacea
- Lead sponsor
- Maruho Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2015
- Completion date
- February 8, 2018
- Enrollment
- 307 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.